Key market opportunities in the shingles vaccine sector include rising elderly populations; expanding healthcare ...
Precision oncology is tailoring treatments based on molecular profiles, while new surgical and radiotherapy methods boost recovery. Despite challenges like late diagnosis and high treatment costs, ...
Q3 2025 Earnings Call November 3, 2025 4:30 PM ESTCompany ParticipantsRobert DeVitaDavid Hung - Founder, President, CEO ...
Merck & Co. began Tuesday with back-to-back deals, revealing separate agreements to pay $150 million upfront for full control of an early-phase asset and pocket $700 million to support an expansive ...
The "Breast Cancer Antibody Drug Conjugates Market Opportunity, Patent, Price, Approved Drug Sales & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's offering. The ...
Conversely, Socionext is plummeting almost 19 percent, Nomura Research Institute is plunging almost 11 percent and ZOZO is sliding more than 8 percent, while Daiichi Sankyo and Aeon are losing more ...
Stockhead on MSN
Health Check: Biotechs canter into November, but the ‘favourites’ have lead in their saddlebags
The ASX biotech sector ran strongly in October, but the big-cap thoroughbreds found the track conditions more challenging. ..
The obesity drug developer has declared a new proposal from Novo “superior” to Pfizer’s original bid as well as an updated ...
The startup claims its medicines may be able to overcome the limitations of conventional antibody-drug conjugates by ...
In a major advance for breast cancer treatment, AstraZeneca and Daiichi Sankyo announced that their drug DATROWAY ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback